Niranjan Bose
@niranjanbose
Managing Director at Gates Ventures. Microbiologist turned strategy consultant turned generalist leader driving change! My own neurons fire up my tweets.
ID:35817996
http://gatesventures.com 27-04-2009 18:31:16
2,4K Tweets
1,5K Followers
1,1K Following
Public Consultation: World Health Organization (WHO) is seeking feedback on Preferred Product Characteristics (PPC) of blood-based biomarkers for Alzheimer's.
This will help ensure the development of affordable and relevant diagnostic products. Deadline to respond is May 10.
bit.ly/3UiEpnL
There is a vital need for comprehensive ADRD data in low and middle-income countries. ADI and 1066 Dementia Research Group offer insights into the epidemiology of dementia across populations. Request access to data harmonized with support from Davos Alzheimer’s Collaborative today.
bit.ly/44yY0Vy
As the world is on the cusp of so many groundbreaking innovations, we at Gates Foundation are proud to announce our latest partnership with Novo Nordisk Foundation & Wellcome to support innovators in global health & development.
Learn more below. gatesfoundation.org/ideas/media-ce…
Solutions start with scientific discovery.
And if we work together, we can improve health faster.
That’s why I’m excited for Wellcome to partner with Novo Nordisk Foundation and Gates Foundation on this $300 million initiative. wellcome.org/news/novo-nord…
Kicking off the Global Science Summit with three global foundations coming together to announce a joint partnership! #globalhealth Gates Foundation Wellcome and Novo Nordisk Foundation
Collaboration will accelerate the discovery of solutions to urgent health challenges.
Here’s why we’re excited to be partnering with Novo Nordisk Foundation and Gates Foundation on a new initiative to support critical research and development.
🧵[1/6]
The Novo Nordisk Foundation, the Gates Foundation and Wellcome will commit an initial total of $300mn over three years and aim to expand their collaboration on technological advances in areas such as mRNA vaccines.
ft.com/content/6218d8…
Last week's #WorldImmunizationWeek was a time to reflect on Africa’s progress towards achieving our public health goals.
Here’s how vaccines have made a transformative impact on #BetterHealthForAll in Africa. 👇
New publication from NASEM Health! Millions in the U.S. suffer from neurodegenerative disorders like #Alzheimers & #Dementia . Read about this recent workshop on scientific advancements that can improve #ADRD prevention & treatment: ow.ly/6SzM50RsGBP #AlzResearch
Our CEO, Mark Roithmayr, spoke today at #ADI2024 on how the ADDF's unique #VenturePhilanthropy model helps accelerate #Alzheimer 's drug discovery & development, discussing the #BiologyOfAging & expressing optimism that recent momentum in the space will usher in a new era of care.
The way dementia is diagnosed has barely changed for decades. Global health systems must step up to embrace new tools & treatments that will change lives.
Pleased to write alongside Sir John Bell in the latest edition of Scientific American 👇
tinyurl.com/5dm987xe
Thank you United Airlines for making the start of our spring break vacation a fabulous one! UA115 to Papeete and thanks to the GS and check in desk for a smooth experience!
We are delighted that Andrew Morris, Director of Health Data Research UK (HDR UK), has been elected as the next President of the Academy of Medical Sciences (@acmedsci).
He will succeed Professor Dame Anne Johnson, formally taking up the role from 25 April 2024.
Find out more 👇
hubs.li/Q02qT4Kv0